Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer

Evaluating the therapeutic response and survival of lung cancer patients receiving first‐line chemotherapy has always been difficult. Limited biomarkers for evaluation exist and as a result histology represents an empiric tool to guide therapeutic decision making. In this study, molecular signatures...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yayi, Song, Lele, Wang, Hao, Chen, Peixin, Liu, Yu, Sun, Hui, Li, Xiaobin, Dang, Shiying, Liu, Guifeng, Liu, Xinyi, Chen, Shifu, Zhang, Xiaoni, Hofman, Paul, Uchino, Junji, Park, Henry S., Pacheco, Jose M., Tabbò, Fabrizio, Xu, Mingyan, Dai, Jiawei, He, Kan, Yang, Yang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887584/
https://www.ncbi.nlm.nih.gov/pubmed/33643802
http://dx.doi.org/10.1002/advs.202003263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887584/
https://www.ncbi.nlm.nih.gov/pubmed/33643802
http://dx.doi.org/10.1002/advs.202003263

Ejemplares similares